KRN7000 applied to asthma research

Plasticity of invariant NKT cell regulation of allergic airway disease is dependent on IFN-gamma production

Exploiting the innate immune system to control allergic asthma

A CD1d-Dependent Antagonist Inhibits the Activation of Invariant NKT Cells and Prevents Development of Allergen-Induced Airway Hyperreactivity

Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma

Alpha-galactosylceramide-induced iNKT cells suppress experimental allergic asthma in sensitized mice: role of IFN-gamma

Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases

Alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation

Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide

 

Meet Funakoshi Company

Please visit our booth at one of these 2012 meetings:

AACR
Booth# 333
April 1-4, 2012

NIH Spring Festival
Booth# 903
April 25-26, 2012